Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-003345·BIORA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
BIORA THERAPEUTICS, INC.
Common Stock, par value $0.001 · CUSIP: 74319F404
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- M.H. Davidson & Co.
Shares: 25,624.00 · Class: 0.56%
- Davidson Kempner Arbitrage, Equities and Relative Value LP
Shares: 880,603.00 · Class: 9.90%
- Davidson Kempner Capital Management LP
Shares: 906,227.00 · Class: 9.90%
- Anthony A. Yoseloff
Shares: 906,227.00 · Class: 9.90%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003345
- Form type
- SCHEDULE 13G/A
- Filer
- BIORA THERAPEUTICS, INC.
- CIK
- CIK 1580063
- Filed
- Aug 04, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership